Fizazi K - Search Results

1

Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology?

Blanchard P, Bossi A, Fizazi K. Blanchard P, et al. Among authors: fizazi k. Curr Opin Urol. 2017 Nov;27(6):580-586. doi: 10.1097/MOU.0000000000000444. Curr Opin Urol. 2017. PMID: 28816713 Review.

2

Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Culine S, Kattan J, Zanetta S, Théodore C, Fizazi K, Droz JP. Culine S, et al. Among authors: fizazi k. Am J Clin Oncol. 1998 Oct;21(5):470-4. doi: 10.1097/00000421-199810000-00010. Am J Clin Oncol. 1998. PMID: 9781602 Clinical Trial.

3

A 10-year clinical experience with intermittent hormonal therapy for prostate cancer.

Prapotnich D, Fizazi K, Escudier B, Mombet A, Cathala N, Vallancien G. Prapotnich D, et al. Among authors: fizazi k. Eur Urol. 2003 Mar;43(3):233-39; discussion 239-40. doi: 10.1016/s0302-2838(03)00004-6. Eur Urol. 2003. PMID: 12600425

4

[Preclinical models of prostate cancer].

Fizazi K, Navone NM. Fizazi K, et al. Bull Cancer. 2005 Feb;92(2):129-41. Bull Cancer. 2005. PMID: 15749642 Free article. Review. French.

5

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L, Soria JC. Fizazi K, et al. Ann Oncol. 2007 Mar;18(3):518-21. doi: 10.1093/annonc/mdl419. Ann Oncol. 2007. PMID: 17322541 Free article.

6

The role of Src in prostate cancer.

Fizazi K. Fizazi K. Ann Oncol. 2007 Nov;18(11):1765-73. doi: 10.1093/annonc/mdm086. Epub 2007 Apr 10. Ann Oncol. 2007. PMID: 17426060 Free article. Review.

7

[Locally advanced prostate cancer: definition, prognosis and treatment].

Plantade A, Massard C, de Crevoisier R, Fizazi K. Plantade A, et al. Among authors: fizazi k. Bull Cancer. 2007 Jul;94(7 Suppl):F50-61. Bull Cancer. 2007. PMID: 17845994 Review. French.

8

The postchemotherapy PSA surge syndrome.

Thuret R, Massard C, Gross-Goupil M, Escudier B, Di Palma M, Bossi A, de Crevoisier R, Chauchereau A, Fizazi K. Thuret R, et al. Among authors: fizazi k. Ann Oncol. 2008 Jul;19(7):1308-1311. doi: 10.1093/annonc/mdn062. Epub 2008 Mar 19. Ann Oncol. 2008. PMID: 18356135 Free article.

9

Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer.

Italiano A, Ortholan C, Oudard S, Pouessel D, Gravis G, Beuzeboc P, Bompas E, Fléchon A, Joly F, Ferrero JM, Fizazi K. Italiano A, et al. Among authors: fizazi k. Eur Urol. 2009 Jun;55(6):1368-75. doi: 10.1016/j.eururo.2008.07.078. Epub 2008 Aug 8. Eur Urol. 2009. PMID: 18706755

10

Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features.

Loriot Y, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Bossi A, Fizazi K. Loriot Y, et al. Among authors: fizazi k. Ann Oncol. 2009 Apr;20(4):703-8. doi: 10.1093/annonc/mdn694. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179557 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters